WebSite > Shanghai Enviko Biotechnologyg Co.,Ltd

Shanghai Enviko Biotechnologyg Co.,Ltd

  • Company Name Shanghai Enviko Biotechnologyg Co.,Ltd
  • Tel -+86-13918629532
  • Email info@envikobio.com
  • WebSite enviko-bio.com/
  • CB Index 58
  •       Shanghai Enviko Biotechnology is a leading company focused on biotechnology, dedicated to developing and manufacturing high-quality synthetic biology products to meet the needs of various industries. Our products are widely used in the pharmaceutical, healthcare, food, cosmetics, chemicals, agricultural and environmental fields, offering sustainable solutions for our clients. Our Mission To revolutionize global wellness through science-backed formulations that: enhance immunity and resilience, prevent and address health concerns, deliver measurable quality-of-life improvements and scientific leadership. Our team of biotechnologists, fermentation engineers, and nutrition scientists pioneers: Natural Bioactives Plant- and microbe-derived compounds via proprietary biosynthesis 100% traceable ingredients with >95% purity Breakthrough R&D Next-gen techniques like CRISPR-enhanced fermentation Industry-leading bioavailability (e.g., 93% absorption rate for key actives) Precision Wellness Custom formulations based on individual biomarkers AI-driven dosage optimization
Shanghai Enviko Biotechnologyg Co.,Ltd Product List
  • Product Name Folic Acid
  • MF C19H19N7O6
  • CAS 104-17-2
  •  
  • Product Name Spinetoram
  • MF C41H65NO10
  • CAS 168316-95-8
  •  
  • Product Name Spinosad
  • MF C41H65NO10
  • CAS 131929-60-7
  •  
  • Product Name Abamectin
  • MF C49H74O14
  • CAS 71751-41-2
  •  
  •  
  •  
  • Product Name Fipronil
  • MF C21H24Cl2O4
  • CAS 148477-71-8
  •  
  • Product Name Imidacloprid
  • MF C9H10ClN5O2
  • CAS 135410-20-8
  •  
  • Product Name Thiamethoxam
  • MF C9H10ClN5O2
  • CAS 138261-41-3
  •  
  •  
  •  
  •  
  •  
  •  
  • Product Name L-Leucine
  • MF C6H13NO2
  • CAS 61-90-5
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •